Subcutaneous Tocilizumab, Alone or with Methotrexate, Demonstrated Superior Efficacy Over Methotrexate Monotherapy in Chinese RA Patients
Deucravacitinib demonstrates broad minimal disease activity component improvements in psoriatic arthritis: Phase 2 trial results
Anifrolumab Shows Durable Benefits in Achieving LLDAS and Remission in SLE: TULIP and Extension Trial Outcomes
No association between abatacept exposure levels and infection risk in early RA: AVERT-2 trial findings
C-reactive protein-albumin-lymphocyte index identified as a promising biomarker for osteoarthritis risk
